How big is the North America nanomedicine industry?

North America nanomedicine market size is anticipated to witness 11.3% CAGR from 2023-2032 due to the strong presence of well-defined regulatory framework for the approval and commercialization of medical products.

How is the demand for nanomedicine driven in oncology?

Nanomedicine industry share from the oncology indication segment is expected to witness 11.5% CAGR from 2023-2032 due to the increasing incidence of cancer.

How are drug delivery applications influencing nanomedicine industry expansion?

The drug delivery application segment held 35.9% of the market share in 2022 driven by the higher need to ensure better drug stability and bioavailability.

What is the nanomedicine market worth?

Global market for nanomedicine recorded USD 210.3 million in 2022 and will showcase 11% CAGR from 2023-2032 due to the increasing advancements and commercialization of technologies, including mRNA and liposome-based vaccines.

Nanomedicine Market Size

Report ID: GMI5909

Published Date: June 2023

Report Format: PDF

Download Free PDF

Nanomedicine Market Size

Nanomedicine Market size is predicted to grow at a (CAGR) of 11% from 2023 to 2032, with a value of USD 210.3 million in 2022. Significant advancements and the recent commercialization of technologies such as mRNA and liposome-based vaccines are projected to propel the expansion of nanomedicines in the coming years. In addition, the growing prevalence of nanotechnology-based pharmaceutical drug delivery technologies, as well as the widespread inefficiency of traditional therapies, offer potential growth opportunities for the nanomedicine business.

Nanomedicine Market

Nanomedicine has the potential to transform the way diseases are treated. Nanoparticles can be utilised to deliver medications to tumours with better accuracy, reducing adverse effects and improving therapeutic success. Nanoparticles can potentially be utilised to transfer genes to cells for the treatment of genetic diseases.

The nanomedicine market is currently in its early phases of development, but it is anticipated to increase significantly in the future years. Several factors are contributing the development of novel nanomedicines, including the increased prevalence of chronic diseases, the rising expense of medication research, and the desire for precision medicine.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

How big is the North America nanomedicine industry?: North America nanomedicine market size is anticipated to witness 11.3% CAGR from 2023-2032 due to the strong presence of well-defined regulatory framework for the approval and commercialization of medical products.
How is the demand for nanomedicine driven in oncology?: Nanomedicine industry share from the oncology indication segment is expected to witness 11.5% CAGR from 2023-2032 due to the increasing incidence of cancer.
How are drug delivery applications influencing nanomedicine industry expansion?: The drug delivery application segment held 35.9% of the market share in 2022 driven by the higher need to ensure better drug stability and bioavailability.
What is the nanomedicine market worth?: Global market for nanomedicine recorded USD 210.3 million in 2022 and will showcase 11% CAGR from 2023-2032 due to the increasing advancements and commercialization of technologies, including mRNA and liposome-based vaccines.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2022

Companies covered: 14

Tables & Figures: 352

Countries covered: 21

Pages: 202

Download Free PDF

Nanomedicine Market Size

Nanomedicine Market Size

Premium Report Details

Industries

Information

Link

Global Headquarters